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A B S T R A C T
Fracture-related infection (FRI) is a common and serious complication in trauma surgery. Accurately
estimating the impact of this complication has been hampered by the lack of a clear deﬁnition. The
absence of a working deﬁnition of FRI renders existing studies difﬁcult to evaluate or compare. In order to
address this issue, an expert group comprised of a number of scientiﬁc and medical organizations has
been convened, with the support of the AO Foundation, in order to develop a consensus deﬁnition.
The process that led to this proposed deﬁnition started with a systematic literature review, which
revealed that the majority of randomized controlled trials in fracture care do not use a standardized
deﬁnition of FRI. In response to this conclusion, an international survey on the need for and key
components of a deﬁnition of FRI was distributed amongst all registered AOTrauma users. Approximately
90% of the more than 2000 surgeons who responded suggested that a deﬁnition of FRI is required. As a
ﬁnal step, a consensus meeting was held with an expert panel. The outcome of this process led to a
consensus deﬁnition of FRI.
Two levels of certainty around diagnostic features were deﬁned. Criteria could be conﬁrmatory
(infection deﬁnitely present) or suggestive. Four conﬁrmatory criteria were deﬁned: Fistula, sinus or
wound breakdown; Purulent drainage from the wound or presence of pus during surgery; Phenotypically
indistinguishable pathogens identiﬁed by culture from at least two separate deep tissue/implant
specimens; Presence of microorganisms in deep tissue taken during an operative intervention, as
conﬁrmed by histopathological examination. Furthermore, a list of suggestive criteria was deﬁned. These
require further investigations in order to look for conﬁrmatory criteria.
Contents lists available at ScienceDirect
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component and decision. The intention of establishing this deﬁnition of FRI was to offer clinicians the
opportunity to standardize clinical reports and improve the quality of published literature. It is important
to note that the proposed deﬁnition was not designed to guide treatment of FRI and should be validated
by prospective data collection in the future.
© 2017 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Fracture-related infection (FRI) is one of the most challenging
musculoskeletal complications in trauma surgery. Currently,Fig. 1. Descriptive ﬂestimating the impact of FRI has been hampered by the lack of
a clear deﬁnition [1]. Interestingly, this issue was previously raised
in an AO/ASIF scientiﬁc supplement publication by Arens et al. in
1996, wherein the authors stated in a combined clinical andow chart of FRI.
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which infection is mentioned, the term ‘infection’ is not deﬁned’ [2]. In
fact, this was conﬁrmed by a recent systematic review, which
showed that only a minority of randomized controlled trials (2%) in
fracture care use any kind of standardized deﬁnition of infection
[3].
The lack of a clear deﬁnition of FRI, mirrors the situation for
Prosthetic Joint Infection (PJI) identiﬁed many years ago [4,5].
The situation for PJI [6] and diabetic foot infection for example
[7], has improved with consensus deﬁnitions emerging in
recent years. However, until now, no consensus deﬁnition for
infection in patients with a fracture has been available. Trauma
surgeons realize that neither the deﬁnition for PJI, nor the
Centers for Disease Control (CDC) guidelines can be easily
extrapolated to fracture cases and that a deﬁnition for FRI needs
to be developed. This was recently conﬁrmed by an interna-
tional survey for registered AOTrauma users. In this survey,
surgeons were asked about the need for a working deﬁnition of
FRI. Approximately 90% of the more than 2000 surgeons who
responded suggested that a deﬁnition of FRI is required (AO
Foundation; data on ﬁle, 2016).
Therefore, a recent effort was made, with the support of the AO
Foundation, to develop such a consensus deﬁnition. The consensus
process was designed speciﬁcally to address only one issue; the
development of this Deﬁnition of FRI. Comparable to the
description by Cats-Baril et al. for the New deﬁnition on PJI [8],
our consensus process had three phases: (1) a phase were experts
exchanged ideas through a modiﬁed Delphi process [8,9] which
was primarily performed with planned videoconferences and
through email; (2) a phase where participants worked face-to-face
to address speciﬁc topics that were agreed upon in phase 1 and
vote on resolutions; and (3) a publication phase. During the ﬁrst
exchange of ideas (phase 1), it was identiﬁed that four main topics
should be addressed to provide knowledge and standards for such
a deﬁnition of FRI. The selected topics were: Classiﬁcation, Location,
Terminology and Diagnostic criteria. The second phase, the
consensus meeting, was convened in December 2016 (Davos,
Switzerland) [10], hosted by the AO Foundation, and composed of a
group of experts, representing various international organizations
(AO Foundation, European Bone and Joint Infection Society (EBJIS))
and prominent orthopaedic trauma hospitals and academic
centers that have a major interest in FRI. As the management of
FRI should be a multidisciplinary effort [11], physicians with
different backgrounds were included (i.e. infectious disease
specialists, orthopaedic trauma surgeons and clinical patholo-
gists). Scientiﬁc input was also provided by researchers active in
this ﬁeld. Prior to the meeting, the experts were asked to review
and consider the published literature on deﬁnitions of infection
developed for PJI and other orthopaedic conditions. During the
meeting, separate sessions addressed the four main topics
previously mentioned. Finally, a ﬁrst concept of the consensus
deﬁnition was proposed, which was further clariﬁed and described
during phase 3.
In the following text an overview is provided of the proposed
deﬁnition.
Deﬁnition of fracture-related infection
This consensus paper describes a proposal for deﬁning infection
related to a fracture. It does not attempt to classify infection,
describe anatomical variations, provide a complete set of
terminology, or outline and guide treatment. Further work is
ongoing regarding these topics.
In the deﬁnitions that describe infection after prosthetic joint
replacement, there is a consensus on the need to use clinical,laboratory and radiological features to conﬁrm or exclude the
presence of infection [6]. This approach is also appropriate for FRI.
It was accepted that some features of FRI can be regarded as
pathognomonic of infection and should be given more weight in
the deﬁnition. Other less speciﬁc features may suggest an infection,
but may also be present in some patients without infection.
Therefore, we deﬁned two levels of certainty around the diagnostic
features. Criteria could be conﬁrmatory (infection deﬁnitely
present if a conﬁrmatory criterion is met) or suggestive (features
associated with infection and requiring further investigation).
In the expert panel meeting, each criterion was discussed
separately with the evidence for its inclusion. Fig. 1 shows a
suggested ﬂow chart that clinicians can use in daily practice
(clinical routine and research) to diagnose and deﬁne FRI.
Conﬁrmatory criteria for FRI
1. Fistula, sinus or wound breakdown (with communication to the
bone or the implant).
2. Purulent drainage from the wound or presence of pus during
surgery.
3. Phenotypically indistinguishable pathogens identiﬁed by cul-
ture from at least two separate deep tissue/implant (including
sonication-ﬂuid) specimens taken during an operative inter-
vention. In case of tissue, multiple specimens (3) should be
taken, each with clean instruments (not superﬁcial or sinus tract
swabs). In cases of joint effusion, arising in a joint adjacent to a
fractured bone, ﬂuid samples obtained by sterile puncture may
be included as a single sample.
4. Presence of microorganisms in deep tissue taken during an
operative intervention, as conﬁrmed by histopathological
examination using speciﬁc staining techniques for bacteria or
fungi.
Suggestive criteria for FRI
1. Clinical signs  any one of:
 Pain (without weight bearing, increasing over time, new-
onset)
 Local redness
 Local swelling
 Increased local temperature
 Fever (single oral temperature measurement of 38.3C
(101F))
2. Radiological signs  any one of:
 Bone lysis (at the fracture site, around the implant)
 Implant loosening
 Sequestration (occurring over time)
 Failure of progression of bone healing (i.e. non-union)
 Presence of periosteal bone formation (e.g. at localizations
other than the fracture site or in case of a consolidated
fracture)
3. A pathogenic organism identiﬁed by culture from a single deep
tissue/implant (including sonication-ﬂuid) specimen taken
during an operative intervention. In case of tissue, multiple
specimens (3) should be taken, each with clean instruments
(not superﬁcial or sinus tract swabs). In cases of joint effusion
arising in a joint adjacent to a fractured bone, a ﬂuid sample
obtained by sterile puncture is permitted.
4. Elevated serum inﬂammatory markers: In musculoskeletal
trauma, these should be interpreted with caution. They are
included as suggestive signs in case of a secondary rise (after an
initial decrease) or a consistent elevation over a period in time,
and after exclusion of other infectious foci or inﬂammatory
processes:
 Erythrocyte sedimentation rate (ESR)
 White blood cell count (WBC)
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5. Persistent, increasing or new-onset wound drainage, beyond the
ﬁrst few days postoperatively, without solid alternative
explanation.
6. New-onset of joint effusion in fracture patients. Surgeons
should be aware that FRI can present as an adjacent septic
arthritis in the following cases:
 Implant material which penetrates the joint capsule (e.g.
femoral nailing)
 Intra-articular fractures
Discussion
Over the past few decades, there has been a growing awareness
of the fact that there is no published deﬁnition of FRI. An obvious
reason is the complexity of the issue. Similarly to PJI, FRI can
manifest in a wide variety of clinical scenarios. However, for FRI
there are not only multiple anatomical locations, but also multiple
fracture patterns, different degrees of soft-tissue injury as well as
different patient conditions (poly- vs. isolated trauma), which
makes inclusion of all FRI patients into one deﬁnition difﬁcult. It
should however be possible to include the majority of patients in a
single deﬁnition, if all the speciﬁc characteristics of FRI and
musculoskeletal trauma patients in general are considered.
Currently, the scarcity of scientiﬁc evidence regarding diagnostic
and treatment concepts, precludes the development of a deﬁnition
for FRI that is based on sound evidence. A possible solution was
described by Cats-Baril et al. in a paper on the development
process for the New deﬁnition of PJI: ‘The lack of evidence for many
aspects of clinical practice compels the medical community to seek
alternatives for development of best practices. A consensus meeting by
international experts is one such alternative’ [8]. Therefore, part of
the aforementioned consensus process consisted of organizing a
meeting composed of experts.
Although the group of experts overall agreed on the deﬁnition
and the value of the different components, there are issues that
need further consideration. The discussion surrounding these
issues is presented in detail below within the four main discussion
topics (Classiﬁcation, Location, Terminology and Diagnostic criteria).
Classiﬁcation
There are multiple classiﬁcations described in the literature
that subdivide FRI into discrete groupings such as acute and
chronic infections, or early, delayed and late onset infections [1,12–
14]. One of the key questions for the experts was: should there be a
single deﬁnition for FRI, or should a deﬁnition be subdivided into
separate deﬁnitions for each classiﬁcation (e.g. acute and chronic
infection)? During the consensus meeting there was a unanimous
decision that there should only be one single deﬁnition for FRI.
Two primary reasons were proposed for this decision: Firstly, a
subdivision would make such a deﬁnition unnecessarily complex
and difﬁcult to use in daily practice. Secondly, the available
classiﬁcations are time-related. These time windows are, to the
best of our knowledge, not based on scientiﬁc evidence, which
supports the view that they are poorly deﬁned for FRI (e.g. time
since injury, or time since onset of symptoms) and somewhat
arbitrary (e.g. a 6 week transition from acute to chronic infection).
All these concerns pose serious problems from a deﬁnition point of
view [3]. Of course, the participants did agree that acute and
chronic infections are different entities that may require different
treatment strategies; however, it should not impact upon the way
clinicians deﬁne FRI.
The experts agreed, that in a later phase, a similar process
should be followed to achieve consensus on a classiﬁcation of FRI
to help develop treatment guidelines.Location
A second challenge in developing a deﬁnition for FRI emerges
with the location of the infection within the surgical site or wound,
and includes descriptions such as ‘superﬁcial incisional infections’
[3]. The CDC published guidelines for surgical site infection (SSI),
which distinguish between superﬁcial incisional, deep incisional
and organ/space infections [15–17]. Bonnevialle et al. state that the
term ‘superﬁcial infection’ is at best arbitrary [18], and poses
particularly challenging problems in FRI. The depth of bacterial
colonization can only be assessed by tissue samples taken under
the subcutaneous tissue layer. This means that superﬁcial swabs
are no longer acceptable for diagnosis and every wound must be
opened to take appropriate samples [18]. In FRI, this would require
the surgeon to open the surgical wound and expose both the
implant and the fracture site in many cases (e.g. ankle fractures). If
the cultures are positive, this then deﬁnes a deep infection.
Furthermore, in clinical studies regarding FRI, these terms (e.g.
superﬁcial and deep) are often used inaccurately or inappropri-
ately, which makes comparison of literature difﬁcult. In clinical
practice, the presence of conﬁrmatory or suggestive signs of an
infection should be sufﬁcient to alert clinicians of the need for
treatment. The speciﬁcs of this treatment may be related to the
nature of the infection (e.g. superﬁcial cellulitis or deep infected
non-union) but this is outside the remit of this deﬁnition proposal.
Unlike PJI, there can be numerous anatomical areas (i.e.
humerus, tibia) involved in FRI. Although each area has its own
features, this deﬁnition does not guide treatment principles.
Subdividing a deﬁnition according to anatomical locations would
make it unnecessarily complex. Also, the criteria used to diagnose
an infection are not dependent on the anatomical location of the
infection.
During the consensus meeting, there was a unanimous decision
that there should not be a subdivision of the deﬁnition for FRI (e.g.
superﬁcial and deep infections, or anatomical locations). The
experts accepted that there might be superﬁcial infections that do
not communicate with the fracture or implant (e.g. cellulitis, pin
site infection) but for the purposes of a deﬁnition (and data
collection), it is important that surgeons deﬁne the presence of
infection, not its extent, localization or classiﬁcation. The superﬁ-
cial nature of a FRI can only be assumed in retrospect, it cannot be
used as an entity that guides treatment. Regarding anatomical
locations, these can be implemented in future treatment concepts
(e.g. classiﬁcation).
Terminology
In the current clinical literature, numerous terms are used with
respect to FRI (i.e. posttraumatic osteomyelitis, osteïtis, deep
infection). Often, no distinction is made between the terms osteitis
and osteomyelitis. Although the term osteomyelitis is used
clinically to signify a bone infection in the English literature
[19], in certain parts of the world, FRI or bone infection is often
referred to as osteitis (i.e ostéite in French speaking countries).
Tiemann and Hofmann suggest that the main difference between
osteitis and osteomyelitis is the way in which the infection arises in
the bone [20]. The term osteitis refers to a bone infection (starting
with cortical bone involvement) most commonly caused by
bacteria, that may lead to the complete destruction of the infected
bone. In contrast, osteomyelitis refers to a primary infection of the
bone marrow (myelitis) with subsequent involvement of the
cortical bone and periosteum. The clinical and investigative
ﬁndings of these diseases may be very similar and it can be
sometimes quite difﬁcult to differentiate between the two [20].
Furthermore, in FRI, terms like osteomyelitis or osteitis are not
useful as the main issue is the presence of bacteria at the fracture
site and around the implant, rather than the semantics of the
pathogenesis of the infection.
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that more uniformity is required in the medical terminology of
infection in musculoskeletal trauma patients. Furthermore, the
experts agreed that terms such as osteomyelitis or osteitis should
be used with caution in clinical studies, as both are very difﬁcult to
distinguish from one another in a clinical setting and, as was
shown in preclinical studies [1], in early cases of infection are not
even present.
The experts also agreed that a more comprehensive term was
required, which encompassed infections with and without
implants and included infection of all parts of the bone (cortical,
medullary, epiphyseal). Fracture-related infection (FRI) was intro-
duced as a more general term. The experts suggest that in the
future, for reasons of uniformity, this term would be used in clinical
publications on patients with infected fractures, in case no further
detailed information (e.g. histopathology) would be available on
the degree of bone involvement.
Diagnostic criteria
The inclusion of diagnostic criteria in the deﬁnition of FRI was a
unanimous decision of the expert panel. Numerous clinical signs
and diagnostic studies were considered. It was recognized that
some features are only present when the fracture is infected
(pathognomonic criteria, which conﬁrms the diagnosis of infec-
tion) and other features may indicate an infection, but could be
present for other reasons (criteria suggesting the diagnosis of
infection). Based on these criteria, the deﬁnition of FRI was
subdivided into Conﬁrmatory and Suggestive criteria (Fig. 1). Again,
it is important to state that this proposal is limited to the diagnosis
of infection and does not attempt to classify infections or provide
guidance for treatment. The goal of describing suggestive criteria is
to stimulate the treating clinician to perform further investigations
in order to look for conﬁrmatory criteria (Fig. 1, dotted line). One
such suggestive criterion, for example, is persistent, increasing or
new-onset wound drainage. This should prompt deep sampling for
culture, which is most frequently done as part of a surgical
debridement.
The panel unanimously agreed that some criteria were
conﬁrmatory of infection, namely ﬁstula, sinus, or wound
breakdown. The presence of these signs deﬁne the ongoing
communication between the fracture or implant and a contami-
nated epithelial surface with the transfer of pathogens to the
fracture or implant environment where their presence will cause
infection, even if indolent. Other local clinical signs (i.e. pain,
redness) were included as suggestive signs. The panel agreed that,
although these signs are subjective, the soft tissue status in
musculoskeletal trauma patients is a crucial aspect that should be
included in the deﬁnition of FRI.
There are a few criteria that need to be addressed separately
because they posed some difﬁculties during the consensus process.
These will be discussed below.
Scientiﬁc data describing the histopathology of FRI is limited [20].
In contrast to the deﬁnition for PJI, the expert panel did not include
the presence of an acute inﬂammatory cell inﬁltrate on histopatho-
logical examination (i.e. PMN count). The reason for this is the lack of
clear scientiﬁc evidence and, more speciﬁcally, agreement on a cut
off value above which FRI can be reliably diagnosed. At the present
time there is still no standardized, reproducible protocol described
for the evaluation of histopathological samples obtained during
surgery for FRI [21]. In daily clinical practice, histopathology ﬁndings
are often presented descriptively rather than in a standardized
objective manner, which makes it difﬁcult for the clinician to
interpret. The inﬂuence of fracture healing and infection on PMN
count therefore requires further studyif it is everto become a reliable
diagnostic parameter for FRI. Recently, a histopathological osteomy-
elitis evaluation score (HOES) has been developed to facilitate thediagnosis [21], but this score will need validation in large clinical
trials. The experts nevertheless agreed that the presence of
microorganisms in deep tissue taken during an operative interven-
tion, as conﬁrmed by histopathological examination using speciﬁc
staining techniques, is a pathognomonic sign for infection. The goal
of this deﬁnition is to include the majority of FRIs and due to the
increasing prevalence of speciﬁc entities like tuberculosis (Ziehl-
Neelsen stain) [22] and invasive fungal infections (Grocott methe-
namine silver stain), especially in immunocompromised patients,
there was a strong consensus to include this sign in the conﬁrmatory
criteria. Gram staining is one of the most known staining techniques
used for the identiﬁcation of both Gram positive and Gram negative
bacteria.Due to lowsensitivity, the experts stated that it should only
be taken into consideration if positive. Overall the results of a Gram
stain should be interpreted with caution (e.g. cases of contamina-
tion).
Over the past few decades various studies have investigated the
performance of molecular diagnostics, more speciﬁc Polymerase
Chain Reaction (PCR), using specimens of different origins,
predominantly in the setting of PJI [21]. Studies related to FRI
are scarce. To our knowledge, over the recent years, only one study
has been published [21]. The results revealed that tissue cultures
were superior to PCR for the diagnosis of FRI. Future research on
this topic is therefore necessary.
Radiological examination is crucial in the evaluation of patients
with FRI. Not only to look for signs of infection, but also to evaluate
implant loosening and bone healing. Different nuclear imaging
techniques have been introduced to help improve the diagnosis of
infection. WBC scintigraphy is one of the most commonly used
diagnostic modalities in this ﬁeld. As was true for PCR, most studies
on these new imaging techniques were performed in peripheral
osteomyelitis including PJI and despite the widely available data on
WBC scintigraphy in peripheral osteomyelitis in general, there is a
lack of studies focusing on FRI [22].
The experts agreed with a strong consensus that PCR, acute
inﬂammatory cell inﬁltrate on histopathological examination (e.g.
PMN count) and nuclear imaging techniques (e.g. WBC scintigra-
phy) should, due to the current lack of scientiﬁc data, not be
included in the current deﬁnition of FRI. The experts acknowledge
that, particularly in longstanding cases of infection, PCR, nuclear
imaging techniques and the presence of an acute inﬂammatory
inﬁltrate could be useful adjunctive diagnostic modalities, but
require validation in well designed, prospective clinical studies
before their inclusion in the diagnostic criteria of FRI.
The experts acknowledge that this deﬁnition of course also has
it limitations. As previously mentioned, research solely focusing
on FRI is scarce, which makes it difﬁcult to have a sound scientiﬁc
basis for such a deﬁnition. On the other hand, this does not mean
that there should not be an attempt to improve daily clinical
practice by the development of such a deﬁnition. Furthermore,
this deﬁnition may be revised in the future on the basis of solid
clinical data from studies that may use this deﬁnition. One ﬁnal
limitation is that this consensus was derived from discussions
within a relatively small group of experts. Increasing the number
of participants within the group would be attractive, however, for
this ﬁrst deﬁnition, the inclusion of only professionals with
signiﬁcant expertise and experience on this topic lends validity to
the deﬁnition.
Conclusion
In conclusion, a deﬁnition of FRI has been designed based on a
stepwise approach. The major stimulus behind this work is to offer
clinicians the opportunity to standardize clinical reports and
improve the quality of published literature. This consensus
deﬁnition should be validated by prospective data collection in
510 W.J. Metsemakers et al. / Injury, Int. J. Care Injured 49 (2018) 505–510order to gather evidence of its use in clinical studies and to prove
that it can become a valuable tool in comparative research.
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